Your browser doesn't support javascript.
loading
Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine.
Bhatla, Neerja; Muwonge, Richard; Malvi, Sylla G; Joshi, Smita; Poli, Usha Rani Reddy; Lucas, Eric; Esmy, Pulikkottil O; Verma, Yogesh; Shah, Anand; Zomawia, Eric; Pimple, Sharmila; Jayant, Kasturi; Hingmire, Sanjay; Chiwate, Aruna; Vashist, Shachi; Mishra, Gauravi; Jadhav, Radhika; Siddiqi, Maqsood; Anantharaman, Devasena; Panicker, Gitika; Butt, Julia; Sankaran, Subha; Kannan, Thiraviam Pillai Rameshwari Ammal; Varghese, Rintu; Kartha, Purnima; Pillai, M Radhakrishna; Waterboer, Tim; Müller, Martin; Sehr, Peter; Unger, Elizabeth R; Sankaranarayanan, Rengaswamy; Basu, Partha.
Afiliação
  • Bhatla N; Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences, New Delhi, India.
  • Muwonge R; Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France.
  • Malvi SG; Tata Memorial Centre Rural Cancer Project, Nargis Dutt Memorial Cancer Hospital, Solapur, India.
  • Joshi S; Jehangir Clinical Development Centre, Jehangir Hospital Premises, Pune, India.
  • Poli URR; Public Health Foundation of India, IIPH-H, Hyderabad, India.
  • Lucas E; Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France.
  • Esmy PO; Department of Oncology, Christian Fellowship Community Health Centre, Ambillikai (near Oddanchathram), India.
  • Verma Y; Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok, India.
  • Shah A; Gujarat Cancer & Research Institute (GCRI), M.P. Shah Cancer Hospital, Civil Hospital Campus, Ahmedabad, India.
  • Zomawia E; National Health Mission, Civil Hospital, Aizawl, India.
  • Pimple S; Department of Preventive Oncology, Centre for Cancer Epidemiology (CCE), Homi Bhabha National Institute, Tata Memorial Centre, Mumbai, India.
  • Jayant K; Tata Memorial Centre Rural Cancer Project, Nargis Dutt Memorial Cancer Hospital, Solapur, India.
  • Hingmire S; Tata Memorial Centre Rural Cancer Project, Nargis Dutt Memorial Cancer Hospital, Solapur, India.
  • Chiwate A; Tata Memorial Centre Rural Cancer Project, Nargis Dutt Memorial Cancer Hospital, Solapur, India.
  • Vashist S; Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences, New Delhi, India.
  • Mishra G; Department of Preventive Oncology, Centre for Cancer Epidemiology (CCE), Homi Bhabha National Institute, Tata Memorial Centre, Mumbai, India.
  • Jadhav R; Jehangir Clinical Development Centre, Jehangir Hospital Premises, Pune, India.
  • Siddiqi M; Cancer Foundation of India, Kolkata, India.
  • Anantharaman D; Cancer Research Division, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India.
  • Panicker G; National Center for Emerging and Zoonotic Infectious Diseases, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Butt J; Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sankaran S; Cancer Research Division, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India.
  • Kannan TPRA; Cancer Research Division, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India.
  • Varghese R; Cancer Research Division, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India.
  • Kartha P; Cancer Research Division, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India.
  • Pillai MR; Cancer Research Division, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India.
  • Waterboer T; Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Müller M; Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sehr P; EMBL-DKFZ Chemical Biology Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany.
  • Unger ER; National Center for Emerging and Zoonotic Infectious Diseases, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Sankaranarayanan R; Kerala Operations, Karkinos Healthcare, Ernakulam, India.
  • Basu P; Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, Lyon, France.
Hum Vaccin Immunother ; 19(3): 2289242, 2023 Dec 15.
Article em En | MEDLINE | ID: mdl-38078840

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Vacinas contra Papillomavirus Limite: Adolescent / Child / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Vacinas contra Papillomavirus Limite: Adolescent / Child / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article